Antidepressant discontinuation effects
Pro Research Analysisby 
Searched over 200M research papers
Antidepressant Discontinuation Effects: Symptoms and Risks
Discontinuation Syndrome and Withdrawal Symptoms
Stopping antidepressants, especially abruptly, can lead to a set of symptoms known as antidepressant discontinuation syndrome. About 20% of patients experience this syndrome, which can include both physical and psychological symptoms such as dizziness, low mood, agitation, changes in appetite, and sleep disturbances. These symptoms are usually mild and temporary for most antidepressants, but can be more severe with certain medications, particularly monoamine oxidase inhibitors (MAOIs) and short-acting selective serotonin reuptake inhibitors (SSRIs) like paroxetine. Longer-acting antidepressants, such as fluoxetine, are less likely to cause severe withdrawal symptoms. Importantly, these symptoms can sometimes be mistaken for a relapse of depression, making careful assessment essential during discontinuation 5107.
Tapering vs. Abrupt Discontinuation
Research shows that abruptly stopping antidepressants increases the risk of relapse and may not provide enough information about adverse events or withdrawal symptoms. Tapering the dose over a period of weeks is generally recommended, but most studies have used short tapering periods (four weeks or less), which may not be sufficient to prevent withdrawal symptoms. Tapering regimens longer than four weeks are rarely studied but may be more effective in reducing withdrawal effects. If severe symptoms occur, reinstating the medication and discontinuing more gradually is advised 17.
Psychological Support and Discontinuation Success
Combining psychological support, such as cognitive behavioral therapy (CBT) or mindfulness-based cognitive therapy (MBCT), with tapering can help patients discontinue antidepressants more successfully and may reduce the risk of relapse. Studies show that cessation rates with psychological support range from 40% to 95%, and relapse rates are similar or lower compared to those who continue medication. However, these interventions are resource-intensive, and more scalable approaches are needed 317.
Relapse Risk After Discontinuation
Discontinuing antidepressants, whether abruptly or by tapering, is associated with a higher risk of relapse compared to continuing medication. In primary care settings, patients who stopped their antidepressants had a significantly higher relapse rate (56%) compared to those who maintained therapy (39%) over a year. This increased risk is also seen in patients with bipolar disorder, where stopping antidepressants soon after remission led to a much higher rate of depressive relapse (70% vs. 36% for those who continued) 891.
Factors Influencing Discontinuation
Not all side effects lead to discontinuation. While common side effects like reduced sexual function and weight gain are frequently reported, they do not necessarily increase the risk of stopping medication. Instead, side effects such as anxiety, agitation, suicidal thoughts, vomiting, and rashes are more strongly associated with discontinuation. Psychiatric comorbidities like PTSD, ADHD, and higher neuroticism also increase the likelihood of stopping antidepressants. Educational attainment appears to protect against discontinuation 26.
Patient Expectations and Discontinuation Symptoms
Emerging research suggests that patients' expectations may influence the occurrence and severity of discontinuation symptoms, not just the pharmacological effects of stopping the medication. Managing expectations and providing clear information may help reduce the burden of withdrawal symptoms and improve the discontinuation process .
Best Practices and Gaps in Research
There is a general consensus that antidepressants should be tapered slowly, with patient education and reassurance throughout the process. Switching to a longer-acting antidepressant before withdrawal may also help. However, there is a lack of high-quality, controlled data to guide best practices, and more research is needed, especially for people with only one or no prior episodes of depression, older adults, and those taking antidepressants for anxiety 17.
Conclusion
Antidepressant discontinuation can lead to withdrawal symptoms and an increased risk of relapse, especially if stopped abruptly or tapered too quickly. Tapering slowly, providing psychological support, and managing patient expectations can help reduce these risks. However, more research is needed to develop clear, evidence-based guidelines for safe and effective discontinuation across different patient populations.
Sources and full results
Most relevant research papers on this topic
Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults.
Abrupt discontinuation without psychological support may increase relapse risk and has insufficient evidence on adverse events compared to continuing antidepressants for depressive and anxiety disorders in adults.
Discontinuation of antidepressant treatment: a retrospective cohort study on more than 20,000 participants
Antidepressant discontinuation is more common with certain side effects, such as anxiety, agitation, suicidal thoughts, vomiting, and rashes, than common ones like reduced sexual function and weight gain.
Managing Antidepressant Discontinuation: A Systematic Review
Cognitive behavioral therapy or mindfulness-based cognitive therapy can help patients discontinue antidepressants without increasing the risk of relapse/recurrence, but are resource-intensive.
Antidepressant discontinuation: a review of the literature.
Antidepressant discontinuation can cause mild to serious symptoms, with shorter acting SSRIs more likely to experience these symptoms than longer acting agents.
Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals
Adverse effects in the first 2 weeks of antidepressant treatment are associated with discontinuation by 6 weeks, with reboxetine being more likely to cause discontinuation than citalopram.
A review of the management of antidepressant discontinuation symptoms
Tapering antidepressants slowly over weeks or months is recommended to avoid discontinuation syndrome, but more research is needed to confirm guidelines and develop appropriate methods for specific drugs.
Maintenance or Discontinuation of Antidepressants in Primary Care.
Patients in primary care who felt well enough to stop antidepressants had a higher risk of depression relapse after 52 weeks compared to those who continued their medication.
Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up.
Discontinuing antidepressants soon after remission increases the risk of depressive relapse in bipolar patients, while the risk of manic relapse remains unchanged.
Antidepressant discontinuation syndrome: A state-of-the-art clinical review.
Antidepressant discontinuation syndrome (ADS) is common and can be minimized with integrated management, pharmacotherapy, and psychotherapy.
DOI